(Q46853511)

25 December 2017

title

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). (English)

1 reference

25 December 2017

gastrointestinal stromal tumor

main subject

1 reference

2

1 reference

25 December 2017

Samuel Singer

7

1 reference

25 December 2017

Murray Brennan

9

1 reference

25 December 2017

Peter Besmer

8

object named as

Peter Besmer

1 reference

25 December 2017

Mithat Gönen

4

object named as

Mithat Gönen

1 reference

25 December 2017

author name string

Ronald P Dematteo

1

1 reference

25 December 2017

Lisa Saran

3

1 reference

25 December 2017

Kui Hin Liau

5

1 reference

25 December 2017

Robert G Maki

6

1 reference

25 December 2017

Cristina R Antonescu

10

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

25 December 2017

published in

Cancer

1 reference

25 December 2017

volume

112

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

608-615

1 reference

25 December 2017

Prognostic value of KIT mutation in gastrointestinal stromal tumors

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Population-based study of the diagnosis and treatment of gastrointestinal stromal tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23199

7 January 2021

Identifiers

DOI

10.1002/CNCR.23199

1 reference

25 December 2017

1 reference

25 December 2017